Analytical Data
-
Gene name
LRP-1 Cluster II
- Application
-
Alternative Names
CD91; LRP; A2MR; APOER; APR; TGFBR5; Alpha-2-Macroglobulin Receptor; Prolow-density lipoprotein receptor-related protein 1; Apolipoprotein E receptor
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q07954
-
Expression Region
Val4441~Ala4544
-
Molecular Weight
16kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRP-1 (Low-Density Lipoprotein Receptor-Related Protein 1) is a multifunctional receptor that plays a critical role in various physiological processes, including lipid metabolism, cell signaling, and clearance of extracellular matrix components. Cluster II refers to a specific domain or segment of LRP-1 that has garnered attention due to its involvement in various pathophysiological conditions such as Alzheimer's disease, cancer, and cardiovascular disorders. Research on LRP-1 Cluster II recombinant proteins is vital for understanding its structural and functional characteristics, as these proteins can provide insights into the receptor's mechanisms of action. Furthermore, the study of recombinant LRP-1 Cluster II proteins may reveal potential therapeutic targets for diseases linked to LRP-1 dysregulation. By elucidating how the receptor interacts with its ligands and mediates cellular responses, researchers aim to develop novel strategies for disease prevention and treatment. The growing interest in harnessing recombinant technology to produce LRP-1 Cluster II proteins underscores the importance of this area of research in enhancing our understanding of receptor biology and its implications for human health.
